Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

Eung Ju Kim; Seung Woon Rha; Sunil P. Wani; Soon Yong Suh; Cheol Ung Choi; Jin Won Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh

doi:10.1016/j.ijcard.2006.08.019

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

Eung Ju Kim, Seung Woon Rha, Sunil P. Wani, Soon Yong Suh, Cheol Ung Choi, Jin Won Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

Department of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Abstract

Despite the fact that the drug-eluting stents (DES) have markedly reduced neointimal proliferation, restenosis is still an open subject. Although DES fracture is very rare, it has been considered as one of the reasons for DES restenosis, however, the mechanism and proper management are not clearly elucidated yet. We describe two cases of sirolimus-eluting stent fracture combined with significant restenosis and suggest the possible revascularization strategies for successful management.

Original language	English
Pages (from-to)	417-419
Number of pages	3
Journal	International Journal of Cardiology
Volume	120
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2006.08.019
Publication status	Published - 2007 Sept 3

Keywords

Drug-eluting stent
Restenosis
Revascularization
Stent fracture

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2006.08.019

Cite this

@article{21d0852fb9f940abaf4843ff40e0ec91,

title = "Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?",

abstract = "Despite the fact that the drug-eluting stents (DES) have markedly reduced neointimal proliferation, restenosis is still an open subject. Although DES fracture is very rare, it has been considered as one of the reasons for DES restenosis, however, the mechanism and proper management are not clearly elucidated yet. We describe two cases of sirolimus-eluting stent fracture combined with significant restenosis and suggest the possible revascularization strategies for successful management.",

keywords = "Drug-eluting stent, Restenosis, Revascularization, Stent fracture",

author = "Kim, {Eung Ju} and Rha, {Seung Woon} and Wani, {Sunil P.} and Suh, {Soon Yong} and Choi, {Cheol Ung} and Kim, {Jin Won} and Park, {Chang Gyu} and Seo, {Hong Seog} and Oh, {Dong Joo}",

year = "2007",

month = sep,

day = "3",

doi = "10.1016/j.ijcard.2006.08.019",

language = "English",

volume = "120",

pages = "417--419",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Coronary stent fracture and restenosis in the drug-eluting stent era

T2 - Do we have clues of management?

AU - Kim, Eung Ju

AU - Rha, Seung Woon

AU - Wani, Sunil P.

AU - Suh, Soon Yong

AU - Choi, Cheol Ung

AU - Kim, Jin Won

AU - Park, Chang Gyu

AU - Seo, Hong Seog

AU - Oh, Dong Joo

PY - 2007/9/3

Y1 - 2007/9/3

N2 - Despite the fact that the drug-eluting stents (DES) have markedly reduced neointimal proliferation, restenosis is still an open subject. Although DES fracture is very rare, it has been considered as one of the reasons for DES restenosis, however, the mechanism and proper management are not clearly elucidated yet. We describe two cases of sirolimus-eluting stent fracture combined with significant restenosis and suggest the possible revascularization strategies for successful management.

AB - Despite the fact that the drug-eluting stents (DES) have markedly reduced neointimal proliferation, restenosis is still an open subject. Although DES fracture is very rare, it has been considered as one of the reasons for DES restenosis, however, the mechanism and proper management are not clearly elucidated yet. We describe two cases of sirolimus-eluting stent fracture combined with significant restenosis and suggest the possible revascularization strategies for successful management.

KW - Drug-eluting stent

KW - Restenosis

KW - Revascularization

KW - Stent fracture

UR - http://www.scopus.com/inward/record.url?scp=34447503305&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2006.08.019

DO - 10.1016/j.ijcard.2006.08.019

M3 - Article

C2 - 17084924

AN - SCOPUS:34447503305

SN - 0167-5273

VL - 120

SP - 417

EP - 419

JO - International Journal of Cardiology

JF - International Journal of Cardiology

IS - 3

ER -

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this